Viewing StudyNCT00034138



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034138
Status: TERMINATED
Last Update Posted: 2007-12-18
First Post: 2002-04-23

Brief Title: A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B4313 in Patients With Ovarian Epithelial Carcinoma
Sponsor: Unither Pharmaceuticals
Organization: Unither Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Ovarian Neoplasms
Keywords:
Name View
immunotherapy View
monoclonal View
antibody View
Stage III ovarian epithelial cancer View
Stage IV ovarian epithelial cancer View